Cell Culture

Can Vero Cells Expressing KREMEN1 Enable CVA6 Vaccine Development?
Biotech & Bioprocessing Can Vero Cells Expressing KREMEN1 Enable CVA6 Vaccine Development?

The increasing prevalence of Coxsackievirus A6 (CVA6) as a major causative agent for Hand, Foot, and Mouth Disease (HFMD) worldwide necessitates the development of an effective vaccine, especially since there is currently no vaccine available against CVA6 infections. CVA6 infections pose a

January 28, 2025
Can New Stem Cell Discovery Revolutionize Glioblastoma Treatment?
Tech & Innovation Can New Stem Cell Discovery Revolutionize Glioblastoma Treatment?

A recent study has unveiled a new type of stem cell in the brain that could potentially revolutionize treatments for adult glioblastoma (GBM), a highly lethal brain tumor. Conducted by a team led by Li Wang and guided by senior author Arnold Kriegstein at the University of California, San Francisco

January 16, 2025
Is 3D Cell Culture Technology the Future of Biomedical Research?
Biotech & Bioprocessing Is 3D Cell Culture Technology the Future of Biomedical Research?

For more than a century, researchers have relied on two-dimensional (2D) methods to culture plant and animal cells in laboratories, confining cell growth to flat surfaces like tiny petri dishes. However, such methods impose significant limits on how cells grow and interact, often producing less

December 31, 2024
Scientists Warn of Potential Catastrophic Risks from Mirror Bacteria
Biotech & Bioprocessing Scientists Warn of Potential Catastrophic Risks from Mirror Bacteria

A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that coul

December 19, 2024
MilliporeSigma Acquires HUB Organoids, Advancing Drug Development
Biotech & Bioprocessing MilliporeSigma Acquires HUB Organoids, Advancing Drug Development

MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of

December 18, 2024
Optimizing Oxygen Levels in Cell Culture for Enhanced Therapy Outcomes
Biotech & Bioprocessing Optimizing Oxygen Levels in Cell Culture for Enhanced Therapy Outcomes

In the ever-evolving field of biotechnology, cell and gene therapy offer unprecedented potential to treat diseases once considered untreatable. However, recent evidence suggests that the conventional methods of culturing cells might be hindering progress. Researchers are now reconsidering the

December 16, 2024
Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later